About | Free Trial

Last Update

2015-03-22T00:00:00.000Z

This profile was last updated on // .

Is this you? Claim your profile.

Wrong Ann Bass?

Dr. Ann Bass D.

Position, Private Practice

Neurology Center of San Antonio P.A

HQ Phone: (210) 490-0016

Neurology Center of San Antonio , TX

Neurology Center of San Antonio P.A

1314 East Sonterra Blvd. # 601

San Antonio, Texas 78258

United States

Company Description

Neurology Center of San Antonio is a partnership of board-certified adult neurologists dedicated to providing compassionate and exemplary care and treatment to patients with neurological disorders. Our physicians and staff value the doctor-patient relatio ... more

Background Information

Employment History

Physician
Capp

Affiliations

Active Member
Texas Medical Association

Active Member
Texas Neurological Society

Active Member
Bexar County Medical Society

Active Member
American Academy of Neurology

Medical Advisory Board
National Multiple Sclerosis Society

Education

MD

medical degree

medical degree

University of Texas Health Science Center

Web References (29 Total References)


Neurology Center of San Antonio, TX | Board certified Adult Neurologists dedicated to providing compassionate and exemplary care to patients in the diagnosis and treatment of neurological disorders.

neurocentersa.com, $reference.date [cached]

Dr. Ann Bass Neurology Center of San Antonio, TX | Board certified Adult Neurologists dedicated to providing compassionate and exemplary care to patients in the diagnosis and treatment of neurological disorders.

...
Dr. Ann Bass
...
Dr. Ann Bass
...
Dr. Ann Bass received her medical degree in May 1993 and completed her neurology residency in June 1997 at the University of Texas Health Science Center in San Antonio, Texas. She has been in private practice with the Neurology Center of San Antonio, P.A. since July 1997 and has been board certified by the American Board of Psychiatry and Neurology since 2002.
Since 2000, Dr. Bass has been specializing in multiple sclerosis and has 1,000+ MS patients under her neurological care and management. She also serves on the Advisory Board for the Texas Chapter of the National Multiple Sclerosis Society (NMSS) since 1999 and has been a principle investigator in many multi-center clinical trials for the treatment of multiple sclerosis. In 2001, Dr. Bass established a comprehensive MS clinic, including an infusion treatment center for MS patients, which was recognized and certified by the NMSS in 2010. She is a regional and national speaker on various topics of multiple sclerosis. Prior to specializing in MS, Dr. Bass also focused her practice on the treatment and management of Parkinson's Disease and has a vast experience with patient selection for and adjustment of deep brain stimulators for the treatment of medically-intractable parkinsonian tremor, dyskinesia, and essential tremor.
Dr. Bass currently serves as an Adjunct Assistant Professor for the neurology department at the UT Medical School in San Antonio and was a clinical instructor for the family practice department at Santa Rosa Hospital (2000-2002). She was awarded "Clinical Instructor of the Year" in 2000 by the American Academy of Family Physicians at Santa Rosa Hospital. She was also named "Texas Super Doctor" by Texas Monthly Magazine in 2006, 2007, 2009 and 2011 and was awarded "Physician Champion of the Year" in 2006 by the American Parkinson's Disease Association and in 2011 by the Parkinson's Outreach Program. Dr. Bass was also awarded "Healthcare Heroes - Outstanding Physician" by the San Antonio Business Journal in 2012. She is an active member of the Consortium of MS Centers, American Academy of Neurology, Texas Neurological Society, Bexar County Medical Society, and Texas Medical Association.


Inside My Story | Life with Multiple Sclerosis & More | Page 2

insidemystory.com, $reference.date [cached]

Never one to turn down the opportunity to speak one on one with these specialists, I was happy to accept their offer and was connected with Dr. Ann Bass, from the Neurology Center of San Antonio.

...
Dr. Bass said the most obvious will be if a person fails two other types of drugs and is still relapsing.
...
Dr. Bass said in the studies, 80% of the people were fine with treatment for just 2 yrs.
...
Dr. Bass said the response is noted fairly fast, within the first few months for most people , with the full effect being felt in 6-12 months.
...
It is no surprise that Dr. Bass said there is a neurologist online community that regularly talks and this is a hotly debated question, because no one really knows that answer.
...
Dr. Bass says Lemtrada will be given by IV, the same as Campath, and the times will be similar.
...
Since our interview I have thought of a few more questions, but I appreciated the openness Dr. Bass displayed discussing the pros and cons of Lemtrada.
...
Thanks to a promotional outreach from a marketing firm to bloggers to talk about this program, I was able to speak by phone with Dr. Ann Bass, the director of The Neurology Center of San Antonio and the lead neurologist for this program. Lights, Camera, Take Action on MS will be comprised of three live events held on different dates in Chicago, Orlando and Houston. The Chicago and Orlando events will also be available to view on the web and taped for on demand viewing at their website. Each of these events will last about two hours, and have a panel comprised of Stowe, Bass, other as yet unspecified medical lifestyle support people, and their patient ambassadors.
...
But Bass says the program will focus on more than just the Genzyme products and include mini-seminars that will offer information on ways to gain better health and be more active as people with MS. She is particularly excited to share the perspective Stowe will add to the caregivers' side of this disease; this is a special group of people that does so much but continues to be in the background with little support or resources


Inside My Story

insidemystory.com, $reference.date [cached]

The PR firm representing Genzyme Sanofi and the launch of their newest MS drug, contacted bloggers with the offer to speak with one of their neurologists about Lemtrada, the trade name for alemtuzamab.  Never one to turn down the opportunity to speak one on one with these specialists, I was happy to accept their offer and was connected with Dr. Ann Bass, from the Neurology Center of San Antonio.  Fortunately they allotted 30 minutes to talk by phone and we used every bit of that and could have used more. There is a lot to talk about - this new MS treatment option has the MS community buzzing with excitement about the potential.

...
Dr. Bass immediately pointed out something I had not caught â€"Lemtrada is approved for relapsing forms of MS and that is not limited to just Relapsing Remitting MS, and it could include Secondary progressive MS. She said there are no plans for a study for its use in primary progressive MS (PPMS), and cited an older study that showed the drug, alemtuzumab showed no benefit in PPMS.  I asked if there might be doctors who would try to use it off label for PPMS and she said that would be highly unlikely because of all the serious warnings that accompany this drug, and the extreme exposure to liability a doctor would face using it in an unapproved manner.
...
Dr. Bass said in the studies, 80% of the people were fine with treatment for just 2 yrs. 20% needed an additional round for the third year and 10 % needed treatment for the fourth year.   The need for additional treatments is based on finding two indications that additional treatment is needed, and could include clinical evidence, EDSS changes, or new lesions and enhancing lesions on MRI exam.
...
It is no surprise that Dr. Bass said there is a neurologist online community that regularly talks and this is a hotly debated question, because no one really knows that answer. Their big debate is while the  lymphocytes were repopulating would there be a benefit to be on something else?
...
Dr. Bass says Lemtrada will be given by IV, the same as Campath, and the times will be similar. A treatment of Lemtrada will involve the infusion to take place over 4-6 hours and that an additional 2 hours of observation, making it at least an eight hour day. Because of the side effects of this drug which is a potent chemotherapy agent,  they recommend pretreating the person with other pharmaceutical to help counteract the side effects.
...
Thanks to a promotional outreach  from a marketing firm to bloggers to talk about this program, I was able to speak by phone with Dr. Ann Bass, the director of The Neurology Center of San Antonio and the lead neurologist for this program. Lights, Camera, Take Action on MS will be comprised of  three live events held on different dates in Chicago, Orlando and Houston. The Chicago and Orlando events will also be available to view on the web and taped for on demand viewing at their website. Each of these events will last about two hours, and have a panel comprised of Stowe, Bass, other as yet unspecified medical lifestyle support people, and their patient ambassadors.  I won’t be anywhere near any of these locations to attend the live program and will have to settle for the rerun.
The panel members will talk about their drug, of course, because that is required by the FDA laws governing contact with potential users of their drug. But Bass says the program will focus on more than just the Genzyme products and include mini-seminars that will offer information on ways to gain better health and be more active as people with MS. She is particularly excited to share the perspective Stowe will add to the caregivers’ side of this disease; this is a special group of people that does so much but continues to be in the background with little support or resources


Inside My Story | Life with Multiple Sclerosis & More

insidemystory.com, $reference.date [cached]

Never one to turn down the opportunity to speak one on one with these specialists, I was happy to accept their offer and was connected with Dr. Ann Bass, from the Neurology Center of San Antonio.

...
Dr. Bass said the most obvious will be if a person fails two other types of drugs and is still relapsing.
...
Dr. Bass said in the studies, 80% of the people were fine with treatment for just 2 yrs.
...
Dr. Bass said the response is noted fairly fast, within the first few months for most people , with the full effect being felt in 6-12 months.
...
It is no surprise that Dr. Bass said there is a neurologist online community that regularly talks and this is a hotly debated question, because no one really knows that answer.
...
Dr. Bass says Lemtrada will be given by IV, the same as Campath, and the times will be similar.
...
Since our interview I have thought of a few more questions, but I appreciated the openness Dr. Bass displayed discussing the pros and cons of Lemtrada.
...
Thanks to a promotional outreach from a marketing firm to bloggers to talk about this program, I was able to speak by phone with Dr. Ann Bass, the director of The Neurology Center of San Antonio and the lead neurologist for this program. Lights, Camera, Take Action on MS will be comprised of three live events held on different dates in Chicago, Orlando and Houston. The Chicago and Orlando events will also be available to view on the web and taped for on demand viewing at their website. Each of these events will last about two hours, and have a panel comprised of Stowe, Bass, other as yet unspecified medical lifestyle support people, and their patient ambassadors.
...
But Bass says the program will focus on more than just the Genzyme products and include mini-seminars that will offer information on ways to gain better health and be more active as people with MS. She is particularly excited to share the perspective Stowe will add to the caregivers' side of this disease; this is a special group of people that does so much but continues to be in the background with little support or resources


Capp's physician, Dr. ...

www.click2houston.com, $reference.date [cached]

Capp's physician, Dr. Ann Bass, a neurologist and multiple sclerosis specialist at Neurology Center of San Antonio, said Lemtrada works by rebooting the immune system and is similar to rebooting a computer.

She said it wipes out the immune system, then allows it to rebuild over time.
"The immune system kind of rebalances itself and it can last for several years," Bass said.
At first, patients need close monitoring, especially for kidney and thyroid function. During the time the immune system is low, patients require frequent health checks.
However, according to Bass, clinical trials have had groundbreaking results
"I have patients in 10 years of remission after two years of treatment," she said.
...
According to Bass, other treatments include daily pills or injections several times a week, while Lemtrada is given intravenously for a five-day period the first year and then a three-day period for the second year.

Similar Profiles

Other People with this Name (20,475)

Other people with the name Bass

Joe Bass
SMI Advertising Inc

Paula Bass
KBC Tools Inc.

Danny Bass
IPG Mediabrands

Amy Bass
Tennessee Health Management Inc

Amber Bass
Austin ENT Clinic

Browse ZoomInfo's Business Contact Directory by City

Browse ZoomInfo's
Business People Directory

Browse ZoomInfo's
Advanced Company Directory